TrialAging2019
Conditional disease-free survival in high-risk renal cell carcinoma treated with sunitinib.
Ning Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this paperpooled itcites it
TrialAging2019
Ning Shao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.